The Fecal Calprotectin Test market is estimated to be valued at US$ 140.6 Mn in 2023 and is expected to exhibit a CAGR of 12.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Fecal calprotectin is a protein that is present in the cytoplasm of neutrophils. When inflamed neutrophils release Calprotectin into the intestines during gastrointestinal ... Read more

Fecal calprotectin testing has emerged as a reliable non-invasive tool for diagnosing and monitoring inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Fecal calprotectin is a protein released from the immune cells in the intestinal tract during inflammatory conditions. Calprotectin levels in the stool help determine the presence, severity, and extent of inflammation. Advantages of fecal calprotectin testing over other diagnostic tests include ease of sample collection ... Read more